iShares Biotechnology ETF
778 hedge funds and large institutions have $3.92B invested in iShares Biotechnology ETF in 2025 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 135 increasing their positions, 340 reducing their positions, and 82 closing their positions.
Holders
778
Holders Change
-43
Holders Change %
-5.24%
% of All Funds
10.45%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.09%
New
56
Increased
135
Reduced
340
Closed
82
Calls
$140M
Puts
$129M
Net Calls
+$11.5M
Net Calls Change
+$349M
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$314M |
| 2 |
2
Citigroup
New York
|
$515M |
| 3 |
3
Morgan Stanley
New York
|
$458M |
| 4 |
4
JPMorgan Chase & Co
New York
|
$105M |
| 5 |
ERSOT
5
Employees Retirement System of Texas
Austin,
Texas
|
$25M |
